Why Technical Debt Matters for Data Scientists in Pharma Innovation

Imagine you’re using HubSpot to track device trial leads for a new insulin pump, and your data pipelines start to slow, dashboards break, or insights become inconsistent. That’s often the result of technical debt — the shortcuts, outdated code, or patchwork fixes that accumulate over time when rapid innovation takes priority. For entry-level data scientists focused on innovation in pharmaceuticals, managing this debt is crucial for maintaining agility and trust in your models and insights.

In 2024, a Pharma Data Innovation Survey revealed that 62% of data teams reported technical debt as a barrier to scaling AI-driven patient monitoring projects. The first step to staying effective is understanding how technical debt builds and how to manage it thoughtfully, especially when working with platforms like HubSpot, widely used in pharma medical devices marketing and CRM.

Here are the seven technical debt management tips every entry-level data scientist should know.

1. Track Your Data Sources and Transformations Inside HubSpot

When you’re experimenting with new device engagement models, you often pull in data from multiple sources: clinical trial results, device telemetry, patient feedback forms, and HubSpot’s CRM records. Without clear tracking, it’s easy to lose sight of where your data came from or how it was altered — a classic source of technical debt.

How to manage it:

• Use version control or simple documentation for your HubSpot workflows and data exports.
• When creating calculated properties in HubSpot, name them clearly (e.g., “Trial_Response_Score_v1”) and store change logs in a shared document.
• Map out your data flow visually — tools like Miro or even Excel can help.

Gotcha:

HubSpot automation and workflows might change silently after updates or user edits. Test your dataflows periodically by comparing samples before and after changes to catch silent breakages early.

2. Automate Testing of Data Quality with Simple Scripts

You can’t innovate effectively if your model ingests dirty or inconsistent data. Manual checks won’t scale; automating quality tests saves time and avoids introducing bugs.

Step-by-step:

• Write small scripts (Python or R) to validate key fields from HubSpot exports — check for missing patient IDs, out-of-range biomarker values, or duplicate trial entries.
• Schedule these checks as batch jobs before running analytics or predictive models.
• Use libraries like Pandas (Python) to build assertions, e.g., assert df['glucose_level'].between(70, 180).all()

Example:

A pharma data team noted they reduced error rates in patient cohort selection by 35% after introducing automated checks on HubSpot lead data.

Limitation:

Automation can’t catch conceptual errors, like a new biomarker introduced without updating your scripts. Pair automation with regular domain expert reviews.

3. Modularize Your Data Pipelines for Faster Experimentation

When testing a new patient risk scoring model, you might start with a simple pipeline: export HubSpot data → clean → feature engineering → model training. But if each step is tangled in a giant script, changing one part becomes risky and slow.

Implementation tips:

• Break your pipeline into independent modules or functions. For example, separate HubSpot data extraction from transformation logic.
• Use tools like Apache Airflow or Prefect for workflow orchestration if your organization allows.
• Save intermediate datasets (like cleaned data) with clear timestamps and versions.

Why it helps:

This way, if you find an error in feature engineering, you only need to re-run that part, not the whole pipeline. It makes experimenting with new features faster and safer.

Caveat:

In smaller teams or without devops support, modularization can feel like overhead. Start small by refactoring scripts incrementally instead of a full rewrite.

4. Embrace Emerging Tech for Real-Time Monitoring in HubSpot

Pharma innovation depends on timely insights — think monitoring adverse event reports linked to implantable devices. Traditional batch reporting might miss early warning signs.

How to start:

• Explore integrating HubSpot with real-time data platforms like Apache Kafka or cloud-native solutions such as AWS Kinesis.
• Set up lightweight alerting for anomalies in patient data streams, using tools like Prometheus or Grafana dashboards.
• For teams without advanced infrastructure, look at no-code integration tools like Zapier that can send HubSpot event data to Slack or email when thresholds are crossed.

Example:

One team tracking heart-device telemetry reduced patient risk detection lag from 48 hours to under 3 hours after implementing real-time dashboards.

Limitation:

Real-time setups can add complexity and cost. They also require teams to respond quickly to alerts, which might not be feasible everywhere.

5. Prioritize Refactoring Based on Business Impact, Not Code Elegance

It’s tempting to rewrite messy scripts into “perfect” code, but time is limited, especially in pharmaceutical projects under regulatory timelines.

How to choose what to fix:

• Use HubSpot analytics and feedback tools like Zigpoll to gather input from marketing and clinical teams on which dashboards or reports are most critical.
• Focus refactoring efforts on components that directly affect high-priority projects like patient safety alerts or regulatory submissions.
• Document “technical debt tickets” in your project tracker with clear consequences (e.g., “Leads scoring report errors delay trial patient stratification by 2 days”).

Anecdote:

A medical-device data team cut their model retraining time by 40% by prioritizing refactoring their HubSpot data ingestion scripts based on input from clinical trial coordinators.

Caveat:

Neglecting low-priority areas can cause long-term issues, so schedule occasional “tech debt sprints” to address smaller but accumulating problems.

6. Use Survey Tools to Continuously Assess Data and Workflow Usability

Beyond automated tests, understanding how data consumers (like clinical analysts or marketing leads) experience your outputs is vital.

Practical steps:

• Deploy short pulse surveys through Zigpoll or Typeform to gather feedback about the clarity and usefulness of HubSpot dashboards or data reports.
• Ask direct questions, e.g., “How confident are you in the patient segmentation data?” or “What information is missing in the device performance dashboard?”
• Analyze trends monthly and adjust your data pipelines or documentation based on this input.

Why it matters:

This feedback loop helps you catch pain points that technical checks might miss — for example, a new biomarker’s data arriving too late for decision-making.

Drawback:

Survey fatigue can reduce response rates. Keep questions brief and stagger surveys to avoid overwhelming your colleagues.

7. Collaborate Early with Compliance and IT Teams to Avoid Rework

In pharma, regulatory compliance (e.g., FDA regulations on medical device data) adds complexity that can turn technical debt into compliance risk.

Best practices:

• Involve your compliance and IT teams when designing new data workflows in HubSpot.
• Clarify data retention policies, audit trails, and patient privacy requirements upfront.
• Use shared documentation platforms (Confluence, SharePoint) to log changes in data handling processes.

Example:

A data science team avoided months of delayed approvals by co-developing a HubSpot-based data tracking solution with IT and the regulatory affairs group from the start.

Limitation:

This slows down initial innovation but saves significant rework later — a tradeoff worth considering when patient safety and compliance are involved.

Prioritizing Technical Debt Management as You Innovate

If you’re just starting, focus first on tracking your data pipelines clearly (#1) and automating basic data quality checks (#2). These lay the groundwork for innovation without spiraling into chaos. Modularizing code (#3) and gathering user feedback (#6) come next, enabling safer experimentation.

Emerging tech (#4) and cross-team collaboration (#7) are essential as your projects grow and regulatory stakes rise. Finally, keep a pragmatic eye on refactoring (#5), fixing what matters most, keeping your team’s velocity intact.

Remember, managing technical debt isn’t about eliminating every flaw immediately. It’s about balancing speed with sustainable practices so your pharmaceutical data science innovations deliver real value without breaking down at critical moments.